Back to Search
Start Over
Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients.
- Source :
-
Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2001 Jan; Vol. 81 (1), pp. 27-39. - Publication Year :
- 2001
-
Abstract
- The aim of this study was to evaluate the differential expression and the function in cell movement and proliferation of the urokinase plasminogen activator (u-PA) system in muscle satellite cells (MSC) of normal individuals and patients with Duchenne muscular dystrophy (DMD). By immunoenzymatic, zymographic, and radioligand binding methods and by quantitative polymerase chain reaction of the specific mRNA we have shown that both normal and DMD MSC produce u-PA and the plasminogen activator inhibitor-1 and express u-PA receptors (u-PAR). During the proliferation phase of their growth-differentiation program, MSC from DMD patients show more u-PAR than their normal counterpart, produce more plasminogen activator inhibitor-1, and release low amounts of u-PA into the culture medium. By Boyden chamber Matrigel invasion assays we have shown that normal MSC are more prone than DMD cells to spontaneous invasion but, when subjected to a chemotactic gradient of u-PA, DMD MSC sense the ligand much better and to a greater extent than normal MSC. u-PA also stimulates proliferation of MSC, but no difference is observable between normal and DMD patients. Antagonization of u-PA/u-PAR interaction with specific anti-u-PA and anti-u-PAR monoclonal antibodies and with antisense oligonucleotides inhibiting u-PAR expression indicates that u-PA/u-PAR interaction is required in spontaneous and u-PA-induced invasion, as well as in u-PA-induced proliferation.
- Subjects :
- Base Sequence
Cell Differentiation drug effects
Cell Division drug effects
Cell Movement
Child
Child, Preschool
DNA Primers genetics
Gene Expression
Humans
In Vitro Techniques
Infant
Male
Muscle, Skeletal drug effects
Muscular Dystrophy, Duchenne genetics
Plasminogen Activator Inhibitor 1 genetics
Plasminogen Activator Inhibitor 1 metabolism
RNA, Messenger genetics
RNA, Messenger metabolism
Receptors, Cell Surface genetics
Receptors, Urokinase Plasminogen Activator
Reverse Transcriptase Polymerase Chain Reaction
Urokinase-Type Plasminogen Activator genetics
Urokinase-Type Plasminogen Activator pharmacology
Muscle, Skeletal cytology
Muscle, Skeletal metabolism
Muscular Dystrophy, Duchenne metabolism
Muscular Dystrophy, Duchenne pathology
Receptors, Cell Surface metabolism
Urokinase-Type Plasminogen Activator metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0023-6837
- Volume :
- 81
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Laboratory investigation; a journal of technical methods and pathology
- Publication Type :
- Academic Journal
- Accession number :
- 11204271
- Full Text :
- https://doi.org/10.1038/labinvest.3780209